Yang Lu
Förmögenhet: 222 M $ per 2026-07-31
Förmögenhet: 222 M $ per 2026-07-31
Yang Lu is the founder of Adlai Nortye Ltd., where he currently serves as the Chairman & Chief Executive Officer.
He founded the company in 2018.
Mr. Lu previously worked as the Managing Director at Sinopep-Allsino Bio Pharmaceutical Co., Ltd. from 2004 to 2006.
Mr. Lu holds an MBA from China Europe International Business School, which he obtained in 2012.
He also completed his undergraduate studies at Xiamen University in 2002.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-10 | 16 990 000 ( 100 % ) | 221 M $ | 2026-07-31 | |
ADLAI NORTYE GROUP LTD. 0,32 % | 2026-05-13 | 299 970 ( 0,32 % ) | 1 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| ADLAI NORTYE LTD. | Verkställande Direktör | 2018-05-09 |
| Företag | Position | Slut |
|---|---|---|
| JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xiamen University
Xiamen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinopep-Allsino Bio Pharmaceutical Co., Ltd.
Sinopep-Allsino Bio Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and sale of peptide and small molecule chemical drugs | Health Technology |
Adlai Nortye Ltd.
Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån